Search

Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.

… Thursday, October 9, 2014 Summary Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors. A recent Memorial Sloan Kettering study suggests new ways to control malignant peripheral nerve sheath tumors (MPNSTs), a rare, aggressive type of soft tissue

In an effort to improve patients’ response to immunotherapy, MSK researchers have studied how microorganisms in the gut affect outcomes in people receiving CAR T therapy.

… Monday, March 14, 2022 In an ongoing effort to improve patients’ response to immunotherapy, MSK researchers have studied how microorganisms in the gut affect outcomes in people receiving chimeric antigen receptor (CAR) T therapy for some types of leukemia and lymphoma. With CAR T therapy, a patient’s

Researchers discover how immune cells called macrophages regulate whether fat is stored or burned.

… Thursday, July 8, 2021 All creatures need to carefully manage their diet to stay alive. Food may not always be available, so organisms from insects to humans have developed an innate sense of when to burn energy and when to save it for later. Living things stockpile energy in the form of fat cells called

A multi-institution team co-led by MSK researchers has pinpointed what could be the early genetic origins of breast cancer.

… Wednesday, November 20, 2024 Researchers at the University of British Columbia (UBC), BC Cancer, Harvard Medical School and Memorial Sloan Kettering Cancer Center (MSK) have pinpointed what could be the early genetic origins of breast cancer — cancer-like mutations appearing in the cells of healthy women

New MSK research identifies new cancer-specific targets for T cell receptor immunotherapy approaches; sheds light on a critical process in sexual reproduction; describes how regulatory T cells help prevent intestinal inflammation; and uncovers how the spleen helps natural killer immune cells adapt to new threats.

… Monday, March 3, 2025 New research from Memorial Sloan Kettering Cancer Center (MSK) identifies new cancer-specific targets for T cell receptor immunotherapy approaches; sheds light on a critical process in sexual reproduction; describes how regulatory T cells help prevent intestinal inflammation; and

New MSK research investigates how pancreatic cancer cells regulate their genome to avoid immune attack; shows promise against glioblastoma in mouse models; and develops a new method to study cancer evolution.

… Thursday, November 21, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) investigates how pancreatic cancer cells regulate their genome to avoid immune attack; shows promise against glioblastoma in mouse models; and develops a new method to study cancer evolution. How pancreatic cancer

An innovative collaboration between basic scientists and clinical researchers has led to a promising new drug for AML.

… Monday, January 18, 2016 Summary A drug called PU-H71, developed at MSK, targets an altered version of a protein that some  acute myeloid leukemia cells need to grow. Blocking the action of this protein may be an effective way to treat these cancers. New research from MSK sheds light on which patients

Memorial Sloan Kettering is sad to note the passing on May 12 of Stephen Sternberg, at the age of 100. Dr. Sternberg spent his entire career at MSK as a surgical pathologist. Widely known as a leader in the field of pathology and highly regarded for his expertise, he was also greatly respected as an editor of major national publications, which garnered him a broad, devoted following around the world.

… Tuesday, July 27, 2021 Memorial Sloan Kettering Cancer Center is sad to note the passing on May 12, 2021, of Stephen Sternberg, at the age of 100. Dr. Sternberg spent his entire career at MSK as a surgical pathologist. Widely known as a leader in the field of pathology and highly regarded for his expertise

Moritz Kircher, MD, PhD, has been selected by the directors of the Dana Foundation as a Dana Neuroscience Scholar.

… Monday, March 5, 2012 Moritz Kircher, MD, PhD , has been selected by the directors of the Dana Foundation as a Dana Neuroscience Scholar. Dana Neuroscience Scholars are new-career investigators who have shown exceptional promise during their training and in their early research. This distinction is Dr

MSK patients that need urgent care may receive care closer to home. That’s when MSK's 34 Shared Care nurses — led by Carol Gemignani — step in.

… Thursday, May 12, 2022 If the Shared Care Nursing team at Memorial Sloan Kettering Cancer Center had a theme song, it could be Randy Newman’s “You’ve Got a Friend in Me.” MSK patients that need urgent care may receive care closer to home. That’s when MSK’s 34 Shared Care nurses — led by Carol Gemignani